Steve, George, and Tamara,

Thank you for all your hard work in putting this shareholder Q&A together.  I think it was a great synopsis of where the company is today.  I will say that most of the topics covered have been addressed in previous news releases and I feel that Steve does a good job of keeping investors apprised of business evolution.

I do want to ask for clarification on a question that was asked as I feel as though Steve skirted the subject and I'm not sure why.  What happened to those 25,000 test kits? Based on previous estimates they should have been sold and replaced a long time ago.  There were hints that some went to Canada in small numbers I'm thinking that means they were given out as freebies.  

I'm a realistic but revenue focused investor.  I'm just trying to set my own revenue goals/estimates as part of my DD.  I dont think what I am asking violates any securities acts.  

I'm also concerned about people having unrealistic expectations on revenue from clinics short term.  I'm very aware of how long it takes to deal with beurocracy for permits, obtain trades in a pandemic etc.  I highly doubt we will see clinic revenue in Q1 which doesn't concern me but I'm a guy that likes total transparency.

Thanks for all the hard work and GLTA,

Brian